---
schema_version: "secwatch.filing_event.v1"
accession: "0000031791-25-000003"
form_type: "8-K"
ticker: "RVTY"
cik: "0000031791"
company_name: "REVVITY, INC."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T04:06:06.049996+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Revvity provides preliminary Q4 revenue ~$730M, 6% organic growth; EPS guidance reaffirmed

## Summary
- Q4 preliminary revenue ~$730M; reported growth ~5%, organic ~6% vs. prior year.
- Full-year 2024 adjusted EPS expected to meet or exceed guidance provided Nov 4, 2024.
- Q4 and full-year 2024 results to be released Jan 31, 2025; conference call at 8am ET.
- CEO Prahlad Singh to present at J.P. Morgan Healthcare Conference on Jan 13, 2025.

## SEC filing metadata
- accession: 0000031791-25-000003
- form_type: 8-K
- ticker: RVTY
- cik: 0000031791
- company_name: REVVITY, INC.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/0000031791-25-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/31791/000003179125000003/pki-20250112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000031791-25-000003
- JSON: https://secwatch.observer/filing/0000031791-25-000003.json
- Plain text: https://secwatch.observer/filing/0000031791-25-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.